Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

If Zanzalintinib (XL092) Isn't Approved by UnitedHealthcare in New Jersey: Formulary Alternatives & Exception Paths

Answer Box: Getting Zanzalintinib (XL092) Coverage in New Jersey Zanzalintinib (XL092) is investigational and typically denied by UnitedHealthcare outside clinical trials. Your fastest path: (1) Check trial eligibility at ClinicalTrials.gov—patients with ≤2 prior TKIs may qualify; (2) If ineligible, request medical exception through OptumRx for compassionate use with

Renewing Uplizna (Inebilizumab) Coverage with UnitedHealthcare in Pennsylvania: Timeline, Documentation & Appeals Guide

Answer Box: Renewing Uplizna Coverage with UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization renewal for Uplizna (inebilizumab) every 6-12 months depending on your plan type. Start the renewal process 30-60 days before your current approval expires to avoid treatment gaps. Submit through the UnitedHealthcare Provider Portal with updated clinical documentation

How to Get Ibrance (Palbociclib) Covered by UnitedHealthcare in Virginia: Complete Forms, Appeals & Contact Guide

Answer Box: Getting Ibrance Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Ibrance (palbociclib) through OptumRx for HR+/HER2- metastatic breast cancer. Submit your PA request via the UnitedHealthcare Provider Portal or fax to 1-844-403-1027. If denied, you have 180 days for internal appeals, then 120 days for

Myths vs. Facts: Getting Eylea and Lucentis Covered by UnitedHealthcare in New Jersey

Quick Answer: UnitedHealthcare requires prior authorization for Eylea and Lucentis in New Jersey, with step therapy typically mandating bevacizumab failure first. If denied, you have 180 days for internal appeals, then can file for external review through New Jersey's IHCAP program administered by Maximus Federal Services. Start by

How to Get Carbaglu (Carglumic Acid) Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Carbaglu Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Carbaglu (carglumic acid) in New Jersey, with 12-month approvals for documented hyperammonemia due to NAGS deficiency, propionic acidemia, or methylmalonic acidemia. Submit through the UHC/OptumRx provider portal with genetic testing, elevated ammonia labs, and

How to Get Zolgensma Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Zolgensma Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Zolgensma (onasemnogene abeparvovec) with specific genetic and clinical criteria. First step: Have your neurologist submit a PA request with bi-allelic SMN1 mutation confirmation, anti-AAV9 antibody titer ≤1:50, and age documentation (<2 years preferred). If

How to Get Opfolda (miglustat) Covered by UnitedHealthcare in North Carolina: Appeals, Timelines, and State Protections

Answer Box: Getting Opfolda Covered in North Carolina Opfolda (miglustat) requires prior authorization from UnitedHealthcare and must be prescribed with Pombiliti for late-onset Pompe disease in adults ≥40 kg. North Carolina's step therapy law gives you strong appeal rights with 72-hour standard decisions and 24-hour expedited reviews for

How Long Does It Take to Get Tagrisso (Osimertinib) Approved by UnitedHealthcare in New Jersey? Complete Timeline Guide

Answer Box: Getting Tagrisso Approved by UnitedHealthcare in New Jersey UnitedHealthcare's standard prior authorization for Tagrisso takes up to 15 business days, with expedited review in 72 hours for urgent cases. You need documented EGFR mutation testing and NSCLC diagnosis. If denied, you have 180 days to file

If Cresemba (Isavuconazole) Isn't Approved by UnitedHealthcare in California: Formulary Alternatives & Exception Paths

Answer Box: When Cresemba Gets Denied If UnitedHealthcare denies Cresemba (isavuconazole) in California, you have three main paths: try a formulary alternative like voriconazole, request a formulary exception with clinical documentation, or file an internal appeal within 65 days. Most denials stem from prior authorization requirements or step therapy—both

Work With Your Doctor to Get Nourianz (Istradefylline) Approved by UnitedHealthcare in New York: Complete Provider Collaboration Guide

Answer Box: Getting Nourianz Approved by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Nourianz (istradefylline) with step therapy requirements. To get approval in New York: 1. Document failed trials of amantadine, MAO-B inhibitors (rasagiline/selegiline), and COMT inhibitors (entacapone) 2. Submit through OptumRx via provider portal or call